---
title: "Novo Nordisk, Telix Pharmaceuticals And Other Big Stocks Moving Lower In Monday’s Pre-Market Session"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/299639314.md"
description: "U.S. stock futures rose, but several major stocks declined in pre-market trading. Novo Nordisk fell 4.8% following disappointing Phase 3 trial results for Cagrisema. Other significant drops included Aligos Therapeutics (-15.1%), Telix Pharmaceuticals (-7.9%) amid merger news, Perspective Therapeutics (-7.3%), Stewards Inc (-7%), Li Auto (-3.5%), New Pacific Metals (-3.3%), and Inventiva SA (-2.7%)."
datetime: "2026-09-21T12:04:08.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/299639314.md)
  - [en](https://longbridge.com/en/news/299639314.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/299639314.md)
generator: "portal-rs"
---

# Novo Nordisk, Telix Pharmaceuticals And Other Big Stocks Moving Lower In Monday’s Pre-Market Session

U.S. stock futures were higher this morning, with the Nasdaq 100 futures gaining around 1% on Monday.

Shares of **Novo Nordisk A/S** (NYSE:NVO) fell sharply in pre-market trading after the company released topline results from Phase 3 REIMAGINE 5 and REDEFINE 9 trials of once-weekly Cagrisema (Cagrilintide and Semaglutide).

Novo Nordisk shares dipped 4.8% to $41.15 in pre-market trading.

Here are some other stocks moving lower in pre-market trading.

-   **Aligos Therapeutics Inc** (NASDAQ:ALGS) fell 15.1% to $4.45 in pre-market trading.
-   **Telix Pharmaceuticals** (NASDAQ:TLX) fell 7.9% to $11.60 in pre-market trading. Telix Pharmaceuticals signed a strategic agreement to lead a merger with ITM Isotope Technologies Munich SE.
-   **Perspective Therapeutics Inc** (NYSE:CATX) fell 7.3% to $2.67 in pre-market trading.
-   **Stewards Inc** (NASDAQ:SWRD) declined 7% to $2.00 in pre-market trading.
-   **Li Auto In**c (NASDAQ:LI) fell 3.5% to $11.72 in pre-market trading. Li Auto, last week, announced the launch of its flagship Li i9 SUV, priced at RMB369,800 for its standard configuration.
-   **New Pacific Metals Corp** (NYSE:NEWP) fell 3.3% to $5.80 in pre-market trading.
-   **Inventiva SA – ADR** (NASDAQ:IVA) declined 2.7% to $3.68 in pre-market trading.

*Photo via Shutterstock*

### Related Stocks

- [SWRD.US](https://longbridge.com/en/quote/SWRD.US.md)
- [ALGS.US](https://longbridge.com/en/quote/ALGS.US.md)
- [TLX.US](https://longbridge.com/en/quote/TLX.US.md)
- [NEWP.US](https://longbridge.com/en/quote/NEWP.US.md)
- [CATX.US](https://longbridge.com/en/quote/CATX.US.md)
- [NVO.US](https://longbridge.com/en/quote/NVO.US.md)
- [IVA.US](https://longbridge.com/en/quote/IVA.US.md)
- [NVOH.US](https://longbridge.com/en/quote/NVOH.US.md)
- [NVOX.US](https://longbridge.com/en/quote/NVOX.US.md)
- [.NDX.US](https://longbridge.com/en/quote/.NDX.US.md)
- [LI.US](https://longbridge.com/en/quote/LI.US.md)
- [02015.HK](https://longbridge.com/en/quote/02015.HK.md)
- [TLX.AU](https://longbridge.com/en/quote/TLX.AU.md)

## Related News & Research

- [Novo Nordisk to Pay Up to $1.3 Billion for Nanexa's Drug Delivery Technology](https://longbridge.com/en/news/300114028.md)
- [Novo Nordisk and UNICEF renew push to prevent childhood obesity](https://longbridge.com/en/news/299766630.md)
- [Novo Nordisk A/S - share repurchase programme | NVO Stock News](https://longbridge.com/en/news/299643883.md)
- [Nanexa AB (publ) (NANEXA) Licenses PharmaShell to Novo for Up to €1.165B](https://longbridge.com/en/news/300057979.md)
- [United Laboratories Wins Novo Milestone for UBT251 Diabetes and Obesity Drug](https://longbridge.com/en/news/300052022.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**